The Cost Effectiveness and Evaluation of Disease Management of Chronic Kidney Disease and High Risk Population
1 other identifier
interventional
411
1 country
1
Brief Summary
This study is being implemented for 3 aims. The first has been to conduct a systematic literatures review on CKD intervention models and their effectiveness. Findings have been adopted in our intervention program. The second purpose is to establish a practical management model or an intervention model for CKD patients and high risk population with the 18-month of follow-up.In the third year, we will use social perspective point to evaluate the costs and the benefits of intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2013
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2013
CompletedFirst Submitted
Initial submission to the registry
November 29, 2013
CompletedFirst Posted
Study publicly available on registry
January 13, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2014
CompletedAugust 1, 2014
July 1, 2014
1.9 years
November 29, 2013
July 31, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change from Baseline in Renal function at 18 months
the baseline, 3rd, 6th, 12th and 18th months.
Secondary Outcomes (1)
Achievement of self management in drug compliance,exercise habit,balance diet at 18 months
the baseline, 3rd, 6th, 12th and 18th months.
Other Outcomes (1)
Compliance to educational programs(exercise, drug, diet) in 18 months
18th months.
Study Arms (3)
general management
OTHERAll participants received a general education with the knowledge on care for early chronic kidney disease recently establishes by the National Health Insurance system. We then used the cross-theoretical model to assess the intervention among the three groups.We collected information on baseline and follow-up data on biochemical and physiological check-ups, health promotion behavior, dietary intake status, self-efficacy and cost etc. The effectiveness assessments have been set for the baseline, 3rd, 6th, 12th and 18th months.
self-management
EXPERIMENTALParticipants in the self-management group are expected to emphasize on self-managed interventions, including self-monitoring and records keeping, self-education with digital video disc (DVD) courses. We negotiated their behavior change set goals for them etc.With one year of intervention period, the 3 groups will be assessed at the 18th months of follow-up next year.
peer-assisted management
EXPERIMENTALThe peer-assisted management group received the peer oriented group activities followed, including group discussions to share experience and sports map etc. With one year of intervention period, the 3 groups will be assessed at the 18th months of follow-up next year.
Interventions
All participants received a general education with the knowledge on care for early chronic kidney disease recently establishes by the National Health Insurance system. We then used the cross-theoretical model to assess the intervention among the three groups.
Participants in the self-management group are expected to emphasize on self-managed interventions, including self-monitoring and records keeping, self-education with DVD courses. We negotiated their behavior change set goals for them etc.
The peer-assisted management group received similar program for 3 months, the peer oriented group activities followed, including group discussions to share experience and sports map etc.
Eligibility Criteria
You may qualify if:
- Age greater than 20 with chronic kidney disease (CKD) stage 1-3a patients and high-risk groups.
You may not qualify if:
- Inability to communicate in Chinese.
- Lack of capacity to write in Chinese.
- Ongoing treatment in dialysis.
- Suffering from major diseases.
- Treatment in cancer or suffering from cancer less than two years.
- Have received organ transplants or bone marrow transplantation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
China Medical University Hospital
Taichung, Taiwan
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Chiu-Ching Huang, doctor
Department of Medicine
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 29, 2013
First Posted
January 13, 2014
Study Start
January 1, 2013
Primary Completion
December 1, 2014
Study Completion
December 1, 2014
Last Updated
August 1, 2014
Record last verified: 2014-07